Notice of Application - 2006
FR Doc E6-13841 [Federal Register: August 22, 2006 (Volume 71, Number 162)] [Notices] [Page 48944] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr22au06-87]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on May 8, 2006, Aldrich Chemical
Company Inc., DBA Isotec, 3858 Benner Road, Miamisburg, OH 45342-4304,
made application by renewal, to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the basic classes of
controlled substances listed in Schedule I and II:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| N-Ethylamphetamine (1475) |
I |
| N,N-Dimethylamphetamine (1480) |
I |
| Aminorex (1585) |
I |
| Gamma hydroxybutyric acid (2010) |
I |
| Methaqualone (2565) |
I |
| Ibogaine (7260) |
I |
| Lysergic acid dethylamide (7315) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Mescaline (7381) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 3,4-Methylenedioxyamphetamine (7400) |
I |
| 3,4-Methylenedioxy-N-ethylamphetamine (7404) |
I |
| 3,4-Methylenedioxy-methamphetamine (7405) |
I |
| 4-Methoxyamphetamine (7411) |
I |
| Psilocybin (7437) |
I |
| Psilocyn (7438) |
I |
| N-Ethyl-1-phenylcyclohexylamine (7455) |
I |
| Dihydromorphine (9145) |
I |
| Normorphine (9313) |
I |
| Acetylmethadol (9601) |
I |
| Alphacetylmethadol Except Levo-Alphacetylmethadol (9603) |
I |
| Normethadone (9635) |
I |
| Norpipanone (9636) |
I |
| 3-Methylfentanyl (9813) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Methylphenidate (1724) |
II |
| Amobarbital (2125) |
II |
| Pentobarbital (2270) |
II |
| Secobarbital (2315) |
II |
| 1-Phenylcyclohexylamine (7460) |
II |
| Phencyclidine (7471) |
II |
| Phenylacetone (8501) |
II |
| 1-Piperidinocyclohexanecarbonitrile (8603) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Benzoylecgonine (9180) |
II |
| Ethylmorphine (9190) |
II |
| Hydrocodone (9193) |
II |
| Isomethadone (9226) |
II |
| Meperidine (9230) |
II |
| Meperidine intermediate-A (9232) |
II |
| Merperidine intermediate-B (9233) |
II |
| Methadone (9250) |
II |
| Methadone intermediate (9254) |
II |
| Dextropropoxyphene, bulk, (non-dosage forms) (9273) |
II |
| Morphine (9300) |
II |
| Normorphine (9313) |
II |
| Thebaine (9333) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture small quantities of the listed
controlled substances to produce isotope labeled standards for drug
testing and analysis.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative/ODL; or any being sent via express mail should be sent
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, VA 22301; and must be
filed no later than October 23, 2006.
Dated: August 15, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-13849 Filed 8-21-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).
|
